Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.
DENTSPLY SIRONA Inc. (Nasdaq: XRAY) regularly issues news and updates that shed light on its role as the world’s largest diversified manufacturer of professional dental products and technologies. Company press releases cover topics such as strategic partnerships, leadership changes, financial results and portfolio decisions, giving investors and dental professionals insight into how the business is evolving.
Recent news has highlighted Dentsply Sirona’s focus on connected dentistry and technology-enabled solutions. The company has announced expanded and renewed distribution partnerships in the United States that provide access to its dental technology portfolio, including systems and imaging solutions referenced in those agreements. These announcements emphasize integrated ecosystems that connect devices, software and services from scanning through design and manufacturing workflows.
News items also address corporate strategy and performance, including quarterly financial results and the introduction of a Return-to-Growth action plan. In these updates, Dentsply Sirona outlines priorities such as putting customers at the center, strengthening the U.S. business, and evolving operations to support innovation and training. Leadership appointments in commercial, finance and regional roles are frequently reported, reflecting the company’s efforts to align its organization with these priorities.
Other press releases describe decisions about the Wellspect Healthcare business, dividend declarations, participation in investor conferences and the conclusion of an SEC Division of Enforcement investigation without enforcement action. Together, these news items provide a detailed view of how Dentsply Sirona manages its portfolio, governance and capital allocation. Readers interested in XRAY can use this news feed to follow developments in connected dentistry, strategic partnerships, governance actions and financial communications from the company.
Dentsply Sirona (Nasdaq: XRAY) has announced that Executive Vice President and Chief Financial Officer Glenn Coleman will resign effective November 7, 2024, to take an executive position at another public company. The dental equipment manufacturer has initiated a search for a new CFO with the help of a leading executive search firm.
CEO Simon Campion praised Coleman's contributions over the past two years, highlighting his role in implementing the company's business transformation plan, initiating ERP modernization efforts, and supporting Employee Resource Groups. Coleman expressed pride in his accomplishments at Dentsply Sirona and confidence in the company's future success under its current leadership team.
Dentsply Sirona (NASDAQ: XRAY) reported Q2 2024 results with net sales of $984 million, down 4.2% year-over-year. The company experienced a net loss of $4 million or ($0.02) per share, compared to net income of $86 million in Q2 2023. Adjusted EPS was $0.49, down from $0.51 in the previous year.
Key highlights include:
- Organic sales decreased by 2.3%
- GAAP gross margin of 51.9%
- Adjusted EBITDA margin of 17.5%
- $150 million in share repurchases during Q2
Dentsply Sirona revised its FY24 outlook, now expecting organic sales to be down 1% to flat, and adjusted EPS between $1.96 and $2.02. The company also announced a second phase of transformation, aiming to reduce annualized operating expenses by $80 to $100 million over 12 to 18 months.
Dentsply Sirona (Nasdaq: XRAY) will host an investor conference call and live webcast on July 31, 2024, at 8:30 am ET to discuss its second-quarter financial results. The presentation will be accessible on the company's investor site. Interested participants can register for the call via a provided link, and a replay will be available post-event.
Dentsply Sirona (Nasdaq: XRAY) has canceled its participation in the Goldman Sachs 45th Annual Global Healthcare Conference due to weather-related flight disruptions.
The company was initially scheduled to take part on June 13, 2024, at 8:00 am ET.
Dentsply Sirona (Nasdaq: XRAY) has announced its participation in two upcoming investor conferences. The company will present at the William Blair 44th Annual Growth Stock Conference on June 5, 2024, at 9:20 am CT and the Goldman Sachs 45th Annual Global Healthcare Conference on June 13, 2024, at 8:00 am ET. Interested parties can access live and replay webcasts via the Dentsply Sirona investor website.
Dentsply Sirona, trading under the Nasdaq symbol XRAY, announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share of common stock.
This equates to an annual rate of $0.64 per share. The dividend is scheduled to be paid on July 12, 2024, to shareholders who are on record as of June 28, 2024.
Dentsply Sirona Inc. (XRAY) will participate in the Bank of America 2024 Health Care Conference on May 15, 2024, and the Stifel 2024 Jaws and Paws Conference on May 29, 2024. Investors can access live audio webcasts on the company's website.
Dentsply Sirona reported a decrease in net sales of 2.6% in the first quarter of 2024, with organic sales down 1.9%. The GAAP gross margin was 53.1%, with net income of $18 million or $0.09 per share. Adjusted EBITDA margin was 16.8%, with adjusted EPS of $0.42. The company is maintaining its FY24 outlook but trending towards the low-end of both organic sales and adjusted EPS ranges. Dentsply Sirona plans to repurchase up to $150 million of its common stock in Q2 2024.
Summary not available.
Summary not available.